Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Beyond LDL: CV experts working to combat residual lipid-related risk
-
- 2 decades of HF
- A look at CV effects of novel cancer therapies Wendy Bottinor, MD; Javid J. Moslehi, MD
- CAC absence with common risk factors may confer low CVD odds
- CHD risk higher in obesity without metabolic syndrome
- Fluorodeoxyglucose PET-CT scans useful for detecting cardiac sarcoidosis
- High rates for rheumatic heart disease persist in poorer areas
- Hospital readmissions may occur shortly after discharge for acute MI
- Intensive, standard BP treatments confer similar quality of life, mental outcomes
-
- Low-dose aspirin may lower risk for preterm preeclampsia
- Statin intensification sufficient for most with atherosclerotic CVD
- Three new studies show benefit of PFO closure on reduced risk for recurrent stroke
- Transvenous pacemaker complications present in 1 in 6 patients by 3 years
- Triple AXEL: Rivaroxaban, warfarin confer similar safety, efficacy in AF-related stroke
- WOSCOPS: Statins reduce mortality in men with very high LDL long term
- Abbott to cease sales of bioresorbable vascular scaffold
- Acarbose fails to lower risk for major adverse CV events in CHD
-
- BIOFLOW-V: Bioresorbable polymer DES superior to durable polymer DES for 12-month TLF
- CANTOS: Canakinumab reduces recurrent CV event rates in MI, inflammation
- CASTLE-AF: Catheter ablation confers improved outcomes for HF, AF
- COMPASS: Rivaroxaban with aspirin improves CV outcomes in atherosclerotic vascular disease
- Exenatide, placebo comparable for major adverse CV events in type 2 diabetes
- Healthy weight behavior influences BP later in life
- Quality improvement program helps control BP in hypertension
- RE-DUAL PCI: Dabigatran plus P2Y12 inhibitor lowers bleeding risk vs. triple therapy
-
- REVEAL: CETP inhibitor added to statin lowers incidence of major coronary events
- SPYRAL HTN-OFF MED: Renal denervation lowers BP in unmedicated patients
- Women with early-onset preeclampsia may have more pronounced LV remodeling after delivery
- CMS plans to cancel cardiac payment models
- Trial Scorecard: CANTOS
- Trial Scorecard: COMPASS
- Trial Scorecard: GUIDE-IT
- Trial Scorecard: LAACS
-
- Trial Scorecard: RE-DUAL PCI
- Trial Scorecard: REVEAL
- Trial Scorecard: Triple AXEL
- Trial Scorecard: VALIDATE-SWEDEHEART